Featured Poster Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Featured Poster Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Featured Poster Session Today - Breaking & Trending Today

Newron to Present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

Published: May 3, 2023

Further data from study 014/015 of evenamide in treatment-resistant schizophrenia confirms potentially relevant role of glutamatergic release modification when added to TRS patients not responding... | May 3, 2023

Source: marketscreener.com

Related Topics:

Sri LankaQueen ElizabethNewron PharmaceuticalsSchizophrenia International Research SocietyOngoing International Randomized StudyWorld CongressFairmont The Queen ElizabethWestin Harbour CastleAssociated With Significant EfficacyResults FromNot Responding To An AntipsychoticFeatured Poster SessionClinically Important EfficacyEvenamide Add OnSession NumberGlutamate ReleaseTreatment Resistant Schizophrenia AlreadyPipeline PresentationBenefits PatientsYear Interim ResultsOngoing International RandomizedNew ChemicalTreatment Resistant SchizophreniaFinal ResultsNegative Syndrome Scale